Procyon Corporation
Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calci… Read more
Procyon Corporation (PCYN) - Net Assets
Latest net assets as of September 2024: $2.29 Million USD
Based on the latest financial reports, Procyon Corporation (PCYN) has net assets worth $2.29 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.20 Million) and total liabilities ($917.12K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.29 Million |
| % of Total Assets | 71.38% |
| Annual Growth Rate | 5.41% |
| 5-Year Change | -21.08% |
| 10-Year Change | 2.58% |
| Growth Volatility | 177.16 |
Procyon Corporation - Net Assets Trend (1996–2025)
This chart illustrates how Procyon Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Procyon Corporation (1996–2025)
The table below shows the annual net assets of Procyon Corporation from 1996 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $2.33 Million | +1.82% |
| 2024-06-30 | $2.29 Million | -12.62% |
| 2023-06-30 | $2.62 Million | -1.88% |
| 2022-06-30 | $2.67 Million | -9.59% |
| 2021-06-30 | $2.95 Million | +36.38% |
| 2020-06-30 | $2.16 Million | +5.09% |
| 2019-06-30 | $2.06 Million | +1.34% |
| 2018-06-30 | $2.03 Million | -11.18% |
| 2017-06-30 | $2.29 Million | +0.75% |
| 2016-06-30 | $2.27 Million | +5.32% |
| 2015-06-30 | $2.16 Million | -9.19% |
| 2014-06-30 | $2.37 Million | +1.00% |
| 2013-06-30 | $2.35 Million | -4.25% |
| 2012-06-30 | $2.45 Million | +5.52% |
| 2011-06-30 | $2.33 Million | +9.04% |
| 2010-06-30 | $2.13 Million | +6.11% |
| 2009-06-30 | $2.01 Million | +1.24% |
| 2008-06-30 | $1.99 Million | +66.51% |
| 2007-06-30 | $1.19 Million | +71.79% |
| 2006-06-30 | $694.23K | +97.22% |
| 2005-06-30 | $352.00K | +847.25% |
| 2004-06-30 | $37.16K | +116.82% |
| 2003-06-30 | $-220.90K | +31.75% |
| 2002-06-30 | $-323.67K | -74.24% |
| 2001-06-30 | $-185.76K | -137.08% |
| 2000-06-30 | $500.93K | +162.62% |
| 1999-06-30 | $-800.00K | -223.00% |
| 1998-06-30 | $-247.68K | -151.97% |
| 1997-06-30 | $476.58K | -5.58% |
| 1996-06-30 | $504.74K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Procyon Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 74857700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.47 Million | 191.82% |
| Other Components | $158.39K | 6.80% |
| Total Equity | $2.33 Million | 100.00% |
Procyon Corporation Competitors by Market Cap
The table below lists competitors of Procyon Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VISTEON
MU:VS51
|
$772.12K |
|
Labrador Technologies Inc
V:LTX
|
$773.02K |
|
O REILLY AUTO - Dusseldorf Stock Exchang
DU:OM6
|
$773.08K |
|
CORP. FIN. ALBA - Dusseldorf Stock Exchang
DU:CSV
|
$774.16K |
|
AETHER CATALYST SOLUT.
F:2QZ
|
$771.49K |
|
IDENTILLECT TECHN. O.N.
F:8ID
|
$771.17K |
|
Eneco Refresh Ltd
AU:ERG
|
$770.68K |
|
Leafbuyer Technologies Inc
PINK:LBUY
|
$770.59K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Procyon Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,287,290 to 2,328,885, a change of 41,595 (1.8%).
- Net income of 33,890 contributed positively to equity growth.
- Other comprehensive income increased equity by 114,660.
- Other factors decreased equity by 106,955.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $33.89K | +1.46% |
| Other Comprehensive Income | $114.66K | +4.92% |
| Other Changes | $-106.95K | -4.59% |
| Total Change | $- | 1.82% |
Book Value vs Market Value Analysis
This analysis compares Procyon Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.65x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.30x to 0.65x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-06-30 | $0.14 | $0.18 | x |
| 1997-06-30 | $0.13 | $0.18 | x |
| 1998-06-30 | $-0.06 | $0.18 | x |
| 1999-06-30 | $-0.15 | $0.18 | x |
| 2000-06-30 | $0.09 | $0.18 | x |
| 2001-06-30 | $-0.02 | $0.18 | x |
| 2002-06-30 | $-0.04 | $0.18 | x |
| 2003-06-30 | $-0.03 | $0.18 | x |
| 2004-06-30 | $0.00 | $0.18 | x |
| 2005-06-30 | $0.04 | $0.18 | x |
| 2006-06-30 | $0.08 | $0.18 | x |
| 2007-06-30 | $0.14 | $0.18 | x |
| 2008-06-30 | $0.24 | $0.18 | x |
| 2009-06-30 | $0.24 | $0.18 | x |
| 2010-06-30 | $0.26 | $0.18 | x |
| 2011-06-30 | $0.28 | $0.18 | x |
| 2012-06-30 | $0.30 | $0.18 | x |
| 2013-06-30 | $0.29 | $0.18 | x |
| 2014-06-30 | $0.29 | $0.18 | x |
| 2015-06-30 | $0.27 | $0.18 | x |
| 2016-06-30 | $0.28 | $0.18 | x |
| 2017-06-30 | $0.28 | $0.18 | x |
| 2018-06-30 | $0.25 | $0.18 | x |
| 2019-06-30 | $0.25 | $0.18 | x |
| 2020-06-30 | $0.26 | $0.18 | x |
| 2021-06-30 | $0.35 | $0.18 | x |
| 2022-06-30 | $0.33 | $0.18 | x |
| 2023-06-30 | $0.32 | $0.18 | x |
| 2024-06-30 | $0.28 | $0.18 | x |
| 2025-06-30 | $0.28 | $0.18 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Procyon Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.46%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.51%
- • Asset Turnover: 1.93x
- • Equity Multiplier: 1.48x
- Recent ROE (1.46%) is below the historical average (20.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | -102.90% | -168.27% | 0.55x | 1.12x | $-569.87K |
| 1997 | -146.32% | -323.49% | 0.37x | 1.21x | $-744.97K |
| 1998 | 0.00% | -230.46% | 1.78x | 0.00x | $-830.69K |
| 1999 | 0.00% | -200.00% | 1.50x | 0.00x | $-520.00K |
| 2000 | -63.48% | -45.24% | 1.15x | 1.22x | $-368.10K |
| 2001 | 0.00% | -59.88% | 5.28x | 0.00x | $-668.11K |
| 2002 | 0.00% | -10.15% | 5.23x | 0.00x | $-105.54K |
| 2003 | 0.00% | 1.94% | 4.31x | 0.00x | $54.10K |
| 2004 | 694.45% | 12.75% | 4.02x | 13.55x | $254.34K |
| 2005 | 89.44% | 14.32% | 3.50x | 1.79x | $279.64K |
| 2006 | 49.30% | 14.79% | 2.54x | 1.31x | $272.81K |
| 2007 | 41.79% | 19.65% | 1.33x | 1.60x | $379.12K |
| 2008 | 39.94% | 30.95% | 0.96x | 1.35x | $594.60K |
| 2009 | 1.23% | 1.04% | 0.87x | 1.35x | $-176.37K |
| 2010 | 5.76% | 4.82% | 0.89x | 1.35x | $-90.55K |
| 2011 | 8.29% | 7.14% | 0.92x | 1.27x | $-39.72K |
| 2012 | 5.23% | 4.59% | 0.96x | 1.19x | $-116.96K |
| 2013 | -4.44% | -3.79% | 1.03x | 1.13x | $-339.34K |
| 2014 | 0.99% | 0.83% | 1.08x | 1.11x | $-213.79K |
| 2015 | -10.13% | -7.87% | 1.10x | 1.17x | $-433.84K |
| 2016 | 4.83% | 3.18% | 1.11x | 1.37x | $-117.47K |
| 2017 | 0.54% | 0.31% | 1.47x | 1.19x | $-216.37K |
| 2018 | -12.59% | -6.36% | 1.70x | 1.16x | $-458.90K |
| 2019 | 1.32% | 0.65% | 1.72x | 1.18x | $-178.68K |
| 2020 | 5.16% | 2.58% | 1.54x | 1.30x | $-104.71K |
| 2021 | 23.53% | 14.71% | 1.11x | 1.44x | $399.25K |
| 2022 | -7.86% | -4.33% | 1.27x | 1.43x | $-476.59K |
| 2023 | -1.92% | -1.07% | 1.32x | 1.36x | $-312.02K |
| 2024 | -14.91% | -6.84% | 1.56x | 1.40x | $-569.87K |
| 2025 | 1.46% | 0.51% | 1.93x | 1.48x | $-199.00K |
Industry Comparison
This section compares Procyon Corporation's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Procyon Corporation (PCYN) | $2.29 Million | -102.90% | 0.40x | $771.70K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |